• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 40 of 100
JPM 2020
NewslettersBiopharma’s big week is upon us
By Sy MukherjeeJanuary 13, 2020
FDA Drug Approvals 2019
NewslettersThe FDA Kept Up Its Drug Approval Streak In 2019
By Sy MukherjeeJanuary 7, 2020
A heart graphic is seen displayed on an Apple Watch in this photo illustration in Warsaw, Poland on April 25, 2019.
CommentaryPharma needs to stop chasing shiny objects and start embracing practical technology
By Paul HudsonJanuary 7, 2020
Big-Pharma-Prescription-Drugs
HealthBig Pharma Raised Prices of Several Prescription Drugs on First Day of 2020
By Chris MorrisJanuary 2, 2020
Sarepta Stock Roche Deal
HealthControversial Biotech Sarepta Keeps Up Unlikely Win Streak With $1.15 Billion Roche Deal
By Sy MukherjeeDecember 23, 2019
Big Pharma ROI
NewslettersBig Pharma’s Return on Investment Plummets to a Dismal 10-Year Low
By Sy MukherjeeDecember 18, 2019
Multiple myeloma MMRF
NewslettersGlaxoSmithKline Hopes to Take on Rivals With Rare Blood Cancer Drug
By Sy MukherjeeDecember 17, 2019
Michigan Uses Drug Trafficking Law to Sue Walgreens and Other Opioid Distributors
HealthMichigan Uses Drug Trafficking Law to Sue Walgreens and Other Opioid Distributors
By David Eggert and The Associated PressDecember 17, 2019
Drugs and Tech Revolutionizinf Healthcare
HealthThe 4 Most Game-Changing Medical Advances of the Past Decade
By Sy MukherjeeDecember 17, 2019
Duchenne Sarepta FDA
NewslettersFDA Approves Sarepta Duchenne Drug in Stunning Reversal
By Sy MukherjeeDecember 13, 2019
New British Chief Executive Officer of French pharmaceutical group Sanofi Paul Hudson talks to journalists at Sanofi headquarters in Paris on October 1, 2019. (Photo by ERIC PIERMONT / AFP) (Photo by ERIC PIERMONT/AFP via Getty Images)
HealthWhy Sanofi’s New CEO Is Trading Diabetes Drugs for Cancer Breakthroughs
By James Paton and BloombergDecember 10, 2019
Cancer Drug Company Acquisitions Showcase Pharma Giants Big Push Into Oncology
HealthCancer Drug Company Acquisitions Showcase Pharma Giants Big Push Into Oncology
By Riley Griffin, James Paton and BloombergDecember 9, 2019
Paul Hudson, chief executive officer of Sanofi, gestures as he speaks during a panel session on the sidelines of the China International Import Expo (CIIE) in Shanghai, China, on Tuesday, Nov. 5, 2019. The CIIE -- now in its second year -- is designed to showcase the countrys desire to shift its economy toward consumption by buying more foreign goods. Photographer: Qilai Shen/Bloomberg via Getty Images
FinanceWhy Sanofi Is Buying a U.S. Cancer Biotech for Nearly 3 Times Its Market Value
By James Paton and BloombergDecember 9, 2019
Sanofi’s New CEO Readies Rx Plan For Pharma Giant
LeadershipSanofi’s New CEO Readies Rx Plan For Pharma Giant
By Susie GharibDecember 9, 2019
Biogen CEO on Controversial Alzheimer’s Drug: ‘There Is Hope’
LeadershipBiogen CEO on Controversial Alzheimer’s Drug: ‘There Is Hope’
By Susie GharibDecember 6, 2019
1...
  • 38
  • 39
  • 40
  • 41
  • 42
...100
Most Popular
Politics
'This is the last warning.' Iran threatens U.S. warships after they throw down the gauntlet for winner-take-all Strait of Hormuzplaceholder alt text
By Fortune EditorsApril 11, 2026
Economy
'People are trying to be creative': Tariff-battered American companies are so cash-starved they are using refund claims as collateral for loansplaceholder alt text
By Fortune EditorsApril 12, 2026
Real Estate
A 93-year-old refused to sell her home to the Masters golf course that’s spent $280 million on expansion: ‘Money ain’t everything’placeholder alt text
By Fortune EditorsApril 12, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.